JAZZ vs METCI
Jazz Pharmaceuticals PLC (JAZZ) versus Ramaco Resources, Inc. 8.250% Senior Notes due 2030 (METCI) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Ramaco Resources, Inc. 8.250% Senior Notes due 2030 (METCI) common stock listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
METCI does not have a complete income-statement cache yet.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. METCI currently screens at market cap $0.
Not investment advice. Open the JAZZ and METCI stock pages for the full models.
Not investment advice.